Thioguanine and low dose thiopurines and allopurinol are both safe options after failure of conventional thiopurines: a comparative analysis of two multicentre cohorts

Vince B. C. Biemans, E. Savelkoul, G. Dijkstra, M. Simsek, Ruben Y. Gabriels, M. Pierik, R. West, N. de Boer, Frank Hoentjen

Research output: Contribution to conferenceAbstractAcademic

Original languageEnglish
Number of pages2
Publication statusPublished - 15-Jan-2020

Cite this